The effect of matrices on the gene expression profile of patient-derived head and neck carcinoma cells for in vitro therapy testing.

Autor: Hyytiäinen, Aini^1,2 (AUTHOR), Korelin, Katja^1,2 (AUTHOR), Toriseva, Mervi^3,4 (AUTHOR), Wilkman, Tommy⁵ (AUTHOR), Kainulainen, Satu⁵ (AUTHOR), Mesimäki, Karri⁵ (AUTHOR), Routila, Johannes^4,6 (AUTHOR), Ventelä, Sami^4,6,7 (AUTHOR), Irjala, Heikki⁶ (AUTHOR), Nees, Matthias^3,4 (AUTHOR), Al-Samadi, Ahmed^1,2,8 (AUTHOR), Salo, Tuula^1,2,9,10,11 (AUTHOR) tuula.salo@helsinki.fi

Publikováno v: Cancer Cell International. 7/24/2023, Vol. 23 Issue 1, p1-22. 22p.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

miR-22 and miR-205 Drive Tumor Aggressiveness of Mucoepidermoid Carcinomas of Salivary Glands

Autor: Naakka, Erika, Barros-Filho, Mateus Camargo, Adnan-Awad, Shady, Al-Samadi, Ahmed, Marchi, Fábio Albuquerque, Kuasne, Hellen, Korelin, Katja, Suleymanova, Ilida, Brown, Amy Louise, Scapulatempo-Neto, Cristovam, Lourenço, Silvia Vanessa, Castilho, Rogério Moraes, Kowalski, Luiz Paulo, Mäkitie, Antti, Araújo, Vera Cavalcanti, Leivo, Ilmo, Rogatto, Silvia Regina, Salo, Tuula, Passador-Santos, Fabricio

Publikováno v: Naakka, E, Barros-Filho, M C, Adnan-Awad, S, Al-Samadi, A, Marchi, F A, Kuasne, H, Korelin, K, Suleymanova, I, Brown, A L, Scapulatempo-Neto, C, Lourenço, S V, Castilho, R M, Kowalski, L P, Mäkitie, A, Araújo, V C, Leivo, I, Rogatto, S R, Salo, T & Passador-Santos, F 2022, ' miR-22 and miR-205 Drive Tumor Aggressiveness of Mucoepidermoid Carcinomas of Salivary Glands ', Frontiers in Oncology, vol. 11, 786150 . https://doi.org/10.3389/fonc.2021.786150

Publisher Copyright: Copyright © 2022 Naakka, Barros-Filho, Adnan-Awad, Al-Samadi, Marchi, Kuasne, Korelin, Suleymanova, Brown, Scapulatempo-Neto, Lourenço, Castilho, Kowalski, Mäkitie, Araújo, Leivo, Rogatto, Salo and Passador-Santos. Objectives

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::a7862deaae822019f36ed5c9ea622f9e
https://findresearcher.sdu.dk:8443/ws/files/199632400/fonc_11_786150.pdf

miR-22 and miR-205 Drive Tumor Aggressiveness of Mucoepidermoid Carcinomas of Salivary Glands.

Autor: Naakka E; Department of Oral and Maxillofacial Diseases, University of Helsinki, Helsinki, Finland.; Translational Immunology Research Program (TRIMM), University of Helsinki, Helsinki, Finland., Barros-Filho MC; Centro Internacional de Pesquisa (CIPE) - A.C.Camargo Cancer Center, São Paulo, Brazil., Adnan-Awad S; Translational Immunology Research Program (TRIMM), University of Helsinki, Helsinki, Finland.; Hematology Research Unit, Department of Clinical Chemistry and Hematology, University of Helsinki, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland., Al-Samadi A; Department of Oral and Maxillofacial Diseases, University of Helsinki, Helsinki, Finland.; Translational Immunology Research Program (TRIMM), University of Helsinki, Helsinki, Finland., Marchi FA; Centro Internacional de Pesquisa (CIPE) - A.C.Camargo Cancer Center, São Paulo, Brazil., Kuasne H; Centro Internacional de Pesquisa (CIPE) - A.C.Camargo Cancer Center, São Paulo, Brazil., Korelin K; Department of Oral and Maxillofacial Diseases, University of Helsinki, Helsinki, Finland.; Translational Immunology Research Program (TRIMM), University of Helsinki, Helsinki, Finland., Suleymanova I; Department of Oral and Maxillofacial Diseases, University of Helsinki, Helsinki, Finland.; Translational Immunology Research Program (TRIMM), University of Helsinki, Helsinki, Finland., Brown AL; Department of Oral Pathology, Faculdade São Leopoldo Mandic, Campinas, Brazil., Scapulatempo-Neto C; Molecular Oncology Research Center, Barretos, and Diagnósticos da América (DASA), Barueri, Brazil., Lourenço SV; Department of Pathology, A.C.Camargo Cancer Center, São Paulo, Brazil.; Department of General Pathology, Dental School, University of São Paulo, São Paulo, Brazil., Castilho RM; Department of Periodontics and Oral Medicine, University of Michigan School of Dentistry, Ann Arbor, MI, United States., Kowalski LP; Department of Head and Neck Surgery and Otorhinolaryngology, A.C.Camargo Cancer Center, São Paulo, Brazil.; Department of Head and Neck Surgery, University of Sao Paulo Medical School, São Paulo, Brazil., Mäkitie A; Department of Otorhinolaryngology - Head and Neck Surgery, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.; Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; Division of Ear, Nose and Throat Diseases, Department of Clinical Sciences, Intervention and Technology, Karolinska Institute and Karolinska Hospital, Stockholm, Sweden., Araújo VC; Department of Oral Pathology, Faculdade São Leopoldo Mandic, Campinas, Brazil., Leivo I; Institute of Biomedicine, Pathology, University of Turku and Turku University Hospital, Turku, Finland., Rogatto SR; Department of Clinical Genetics, University Hospital of Southern Denmark, Vejle, Denmark.; Institute of Regional Health Research, University of Southern Denmark, Odense, Denmark., Salo T; Department of Oral and Maxillofacial Diseases, University of Helsinki, Helsinki, Finland.; Translational Immunology Research Program (TRIMM), University of Helsinki, Helsinki, Finland.; Department of Pathology, Helsinki University Hospital, Helsinki, Finland.; Cancer and Translational Medicine Research Unit, University of Oulu, Oulu, Finland.; Medical Research Center, Oulu University Hospital, Oulu, Finland., Passador-Santos F; Department of Oral Pathology, Faculdade São Leopoldo Mandic, Campinas, Brazil.

Publikováno v: Frontiers in oncology [Front Oncol] 2022 Feb 09; Vol. 11, pp. 786150. Date of Electronic Publication: 2022 Feb 09 (Print Publication: 2021).